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A universal feature of stable RNAs is that they are transcribed as 3′
extended precursor molecules that undergo subsequent process-
ing events, generally exonuclease digestion, to generate the 3′ end
of the mature molecule. Conversely, RNAs such as cytoplasmic
mRNAs, nuclear pre-mRNA and the RNA spacer fragments gen-
erated during processing reactions can also be shortened from the
3′ end but these molecules are rapidly and completely degraded.
Notably, under circumstances such as the formation of incorrect-
ly assembled ribonucleoprotein (RNP) particles, a precursor
RNA that is usually processed to the mature RNA may become a
substrate for rapid degradation. Recent data from genetic analy-
ses in the yeast Saccharomyces cerevisiae have shown that many of
the enzymes that function in RNA 3′ end maturation processes
also function in RNA degradation pathways. The regulation of
the activities of these enzymes is therefore of great importance.
A major group of RNA processing/degradative enzymes con-
sists of the 3′→5′ exoribonucleases, ribonucleases that progres-
sively digest RNAs specifically from the 3′ end. The genome of 
S. cerevisiae is predicted to encode at least 19 3′→5′ exoribonu-
cleases1–4, most of which have one or more assigned functions in
RNA processing. In contrast to Escherichia coli, in which the
eight known 3′→5′ exoribonucleases function independently of
one another5, many of the eukaryotic 3′→5′ exoribonucleases
form a multienzyme complex known as the exosome3,4 (Table 1).
In yeast, this complex contains all of the 3′→5′ exoribonucleases
that are known to be essential for viability, suggesting that it
plays a key role in RNA 3′ end maturation and turnover.
Structural models for the exosome
Two related exosome complexes have been identified that are
believed to represent cytoplasmic and nuclear forms4. In yeast, 10
proteins are present in both the nuclear and cytoplasmic forms of
the complex. Three of these have been demonstrated to have
3′→5′ exoribonuclease activity in vitro3 and a further six have
high sequence homology to characterized 3′→5′ exoribonucleas-
es (Table 1). Although not formally demonstrated, it therefore
seems highly plausible that 9 of the 10 proteins are exoribonucle-
ases. The exception is Csl4p/Ski4p, which is not known to have
exonuclease activity and is not clearly homologous to any charac-
terized exonuclease, but does not contain a predicted RNA bind-
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ing domain similar to that present in the E. coli ribosomal protein
S1 (S1 RBD). The nuclear exosome includes an additional com-
ponent, the 3′→5′ exoribonuclease Rrp6p, which is homologous
to E. coli RNase D4,6. Strikingly, neither complex has obvious
structural or regulatory subunits. They do, however, include
enzymes with distinctly different activities (Table 1).
Recombinant Rrp44p and Rrp6p, like their E.coli homologs
RNase R and RNase D, are hydrolytic enzymes, as is Rrp4p. These
nucleases use water as the attacking group, releasing nucleotide 5′
monophosphates. In contrast, Rrp41p is a phosphorolytic
enzyme, as is E.coli RNase PH, using inorganic phosphate as the
attacking group and releasing nucleotide 5′ diphosphates.
Moreover, Rrp4p is distributive, whereas Rrp41p and Rrp44p are
processive3. Once bound, processive nucleases remain associated
with the RNA and digest the substrate to completion. Conversely,
distributive nucleases repeatedly bind and dissociate from the
substrate, removing nucleotides one at a time.
The yeast cytoplasmic complex (lacking Rrp6p) has a predict-
ed mass of 401 kDa based on the known components and has an
experimentally determined sedimentation coefficient of 14S
(ref. 3). Fractionation experiments suggest that the exosome has
a very stable ‘core’ consisting of the six RNase PH homologs and
the three S1 RBD-containing proteins Rrp4p, Rrp40p and Csl4p.
These proteins remain stably associated with one another at
Mg2+ concentrations of up to 1.6 M upon Mg2+ concentration
gradient elution of immunoaffinity-purified exosome prepara-
tions, independent of the epitope-tagged protein4 (P.M. & D.T.,
unpublished results). Rrp44p is less tightly bound and can be
eluted at a moderate Mg2+ concentration of ∼ 0.6 M.
The yeast nuclear exosome processes 3′ extended precursors of
the 5.8S ribosomal RNA (rRNA), the U1, U2, U4 and U5 small
nuclear RNAs (snRNAs) and many small nucleolar RNAs
(snoRNAs), as well as degrading unspliced pre-mRNAs and pre-
rRNA spacer regions4,7–12. The cytoplasmic exosome degrades
mRNAs in a 3′→5′ direction following deadenylation13. Genetic
depletion of any individual exosome component inhibits all
nuclear activities of the complex. Furthermore, cytoplasmic
3′→5′ mRNA degradation is inhibited by mutation of any tested
component of the cytoplasmic exosome but not by the absence of
Rrp6p, which is specific for the nuclear complex11 (P.M. & D.T.,
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The exosome complex of 3′→5′ exoribonucleases functions in both the precise processing of 3′ extended
precursor molecules to mature stable RNAs and the complete degradation of other RNAs. Both processing and
degradative activities of the exosome depend on additional cofactors, notably the putative RNA helicases Mtr4p
and Ski2p. It is not known how these factors regulate exosome function or how the exosome distinguishes RNAs
destined for processing events from substrates that are to be completely degraded. Here we review the available
data concerning the modes of action of the exosome and relate these to possible structural arrangements for the
complex. As no detailed structural data are yet available for the exosome complex, or any of its constituent
enzymes, this discussion will rely heavily on rather speculative models.



































unpublished results). These results strongly suggest that all the
substrates are processed by intact exosome complexes, rather
than by individual enzymes. Notably, all of the characterized exo-
some substrates are RNP complexes and not naked RNAs.
Clear homologs of the yeast exosome proteins are present in
other eukaryotes, including humans4,14 (Table 1) and are orga-
nized in a comparable complex that also has associated exonu-
clease activity (R. Brouwer, C. Allmang, R. Raijmakers, Y. van
Aarssen, W. Vree Egberts, E. Petfalski, W.J. van Venrooij, 
D. T. & G. Pruij, unpublished results). All tested human
homologs are present in nuclear and cytoplasmic complexes that
are recognized by autoimmune antibodies present in patients
with polymyositis-scleroderma overlap syndrome (PM-Scl). As
in yeast, human nuclear and cytoplasmic forms exist which differ
by the presence of PM-Scl100 (the homolog of Rrp6p) specifical-
ly in the nuclear complex. Four human homologs tested have
been shown to be functional when expressed in yeast, comple-
menting mutations in the corresponding yeast genes3,15,16
(R. Brouwer, C. Allmang, R. Raijmakers, Y. van Aarssen, W. Vree
Egberts, E. Petfalski, W.J. van Venrooij, D. T. & G. Pruij, unpub-
lished results; Table 1). The structural organization of the com-
plex must therefore be sufficiently conserved to allow
incorporation of the human homologs into the yeast exosome.
Two characteristics of the exosome are of particular signifi-
cance for potential structural models. Firstly, although the indi-
vidual recombinant proteins are active in vitro, the exosome
complex purified from yeast lysates exhibits little activity3. This
suggests that the assembly of the ribonucleases into the exosome
complex largely represses their enzymatic activities. Activation of
the exosome would therefore be expected to require additional
factors that are not stably associated with the complex. Consistent
with this model, genetic analyses have identified proteins that are
required for exosome-mediated RNA processing reactions but
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that are not found in purified exosome preparations. These
potential exosome cofactors include the putative ATP-dependent
RNA helicases Mtr4p and Ski2p, the putative GTPase Ski7p and
the Ski3p and Ski8p proteins12,13 (A. van Hoof & R. Parker, pers.
comm.; Table 1). Secondly, different exosome substrates have
very different fates. Precursors to mature RNAs, such as rRNAs,
snRNAs and snoRNAs, undergo limited processing reactions that
remove nucleotides from the end of the RNA, thereby generating
products with discrete 3′ ends. Other substrates, including pre-
rRNA spacer fragments, aberrant pre-rRNA processing interme-
diates, nuclear pre-mRNAs and cytoplasmic mRNAs, are rapidly
and processively degraded to completion. Moreover, at least for
pre-mRNAs, this degradative activity is regulated10.
Any model for the organization of the exosome should there-
fore explain: (i) how 10 exonucleases can be maintained simulta-
neously in an inactive state; (ii) how each can be activated and
gain access to macromolecular substrates; and (iii) how different
substrates (or indeed the same substrate under different circum-
stances) can be subjected to either limited, accurate digestion or
complete, processive degradation.
The proteasome analogy
One model recently proposed for the exosome14 is analogous to
the structural arrangement of the 20S proteasome complex
(recently reviewed by Baumeister et al.17 and DeMartino and
Slaughter18). In this model, the active sites of the enzymes are
directed towards the hollow center of a tubular structure and
are therefore only accessible to substrates that enter this struc-
ture (Fig. 1a). The function of the Mtr4p and Ski2p helicases
would then be directly analogous to the ATPases of the protea-
some regulatory subunit, which are thought to unfold the sub-
strate and channel the polypeptide chain into the degradative
complex19.
Fig. 1 Models for the activation of the exosome. a, Proteasome model. Access to the active sites of the exonucleases in the exosome is regulated by
the RNA helicase Mtr4p or Ski2p (blue oval). Displacement or reorganization of the helicase occurs upon interaction with the RNP substrate. ATP
hydrolysis by the activated RNA helicase unfolds the RNA structure and channels the free 3′ end into the lumen of the exosome. b, Allosteric model.
The RNA helicase interacts directly with the RNP substrate, recognizing specific marker proteins. The ATPase activity of the RNA helicase allows the
exosome to be remodeled into an appropriately active form. The helicase may interact with the RNP substrate, either associated with the exosome
or in its absence; for simplicity only the latter case is shown.
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There are, however, several significant differences between the
two complexes. The proteasome can be isolated from cell
extracts in association with the regulatory ATPase complex,
whereas the exosome is not found as a stable complex with either
Mtr4p or Ski2p. Furthermore, a key functional difference
between the two complexes is that while both degrade many
diverse substrates in an apparently processive manner, only the
exosome generates precise ends of substrates via a clearly exolyt-
ic processing mechanism. The proteasome is required for the
synthesis of at least one polypeptide, the p50 product of the NF-
κB1 gene20, which corresponds to the N-terminal portion of a
functionally distinct protein, p105. However, the mechanism of
NF-κB p50 production is unclear21,22 and convincing evidence
exists, at least in mammalian cells, for an initial endoproteolytic
cleavage event23. Thus, while the structural analogy of the exo-
some to the proteasome works well for RNA degradation path-
ways, it is clearly less compatible with accurate 3′ end formation
in RNA processing events. Furthermore, it is hard to envisage
how such an arrangement would allow the exosome to degrade
RNAs in a distributive manner, as is observed in vitro with the
exosome complex purified from cell lysates or with recombinant
Rrp4p3,24.
An allosteric alternative
An alternative model is that the enzymes are regulated by
allosteric mechanisms. In this case, the degradation or process-
ing of a given RNA substrate would be achieved by the selective
activation of one or more distinct enzymes upon substrate
recognition (Fig. 1b). This concept envisages a more fluid struc-
ture for the exosome, with the potential to adopt a number of
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different activated forms that could perform distinct activities,
depending upon which enzymes are ‘exposed’.
Such an allosteric mechanism would permit both the tight reg-
ulation of ribonuclease activity and the versatility of nucleolytic
activities suggested by in vivo analyses. Data supporting an
allosteric mode of activation for the exosome come from in vitro
studies on the purified complex (P.M. & D.T., unpublished
results). Enzymatic analysis of fractionated cell extracts revealed
that the majority of exosome activity is associated with only a
small fraction (∼ 1%) of the total complex population. This high-
ly active fraction is itself quite heterogeneous; several distinct
exonucleolytic activities were observed, even on a short unstruc-
tured substrate, which could be partially resolved using bio-
chemical fractionation procedures. No clear differences,
however, were observed in the protein compositions of these
active fractions and the bulk exosome population, strongly sug-
gesting that the active forms correspond to complexes that are
arranged in distinct structural conformations. These active frac-
tions presumably represent complexes that were trapped in a
given conformation upon cell lysis. It is unclear whether they
represent complexes that had been activated but had not yet ini-
tiated processing, complexes that had terminated processing but
had not yet returned to the latent state, or complexes that were
actively engaged in processing.
Energetics and substrate recognition
Considerable free energy is released during RNA folding and
RNP particle assembly processes, and the unfolding of these
structures presumably entails a substantial energetic cost.
What sources of energy are available to the exosome to facili-
Table 1 Exosome components and cofactors
Protein Gene Activity1 Motifs/homologs Deletion phenotype Human homolog2 Comments
Rrp4p YHR069c Hydrolytic, distributive S1 RBD Essential hRrp4p (43%) hRrp4p complements 
3′→5′ exonuclease rrp4-1
Rrp40p YOL142w (Hydrolytic, distributive S1 RBD Essential hRrp40p (30%) Homologous to Rrp4p
3′→5′ exonuclease)
Csl4p/Ski4p YNL232w ? S1 RBD Essential hCsl4p (48%) hCsl4p complements
csl4-1
Rrp41p/Ski6p YGR195w Phosphorolytic, processive RNase PH Essential hRrp41p (35%) hRrp41p complements 
3′→5′ exonuclease GAL:rrp41
Rrp42p YDL111c (Phosphorolytic, processive) RNase PH Essential
3′→5′ exonuclease
Rrp43p YCR035c (Phosphorolytic, processive RNase PH Essential
3′→5′ exonuclease)
Rrp45p YDR280w (Phosphorolytic, processive RNase PH Essential PM-Scl 75 (38%) Human KIAA0116 and 
3′→5′ exonuclease) OIP2 also homologous
Rrp46p YGR095c (Phosphorolytic, processive RNase PH Essential hRrp46p (26%)
3′→5′ exonuclease)
Mtr3p YGR158c (Phosphorolytic, processive) RNase PH Essential
Rrp44p/Dis3p YOL021c Hydrolytic, processive RNase R (vacB) Essential hDis3p (45%) hDis3p complements 
3′→5′ exonuclease dis3-81
Rrp6p YOR001w hydrolytic 3′→5′ exonuclease RNase D ts-lethal PM-Scl 100 (32%) Component only of 
nuclear complex
Cofactors
Mtr4p/Dob1p YJL050W (ATP-dependant helicase) DEAD box Essential
Ski2p YLR398C (ATP-dependant helicase) DEAD box Nonessential SKIV2L (38%)
Ski3p YPR189W TPR repeat Nonessential KIAA0372 (20%)
Ski7p YOR076c (GTPase) Nonessential High similarity 
Ski8p YGL213C WD repeat Nonessential to Hbs1p
1Demonstrated enzymatic activities are listed; activities in parentheses are predicted from sequence homology.
2For the human homologs, the numbers given indicate the percentage identity along the entire length of the protein.



































tate the unfolding and processing or degradation of its sub-
strates?
The equilibrium constants for RNA degradation by the phos-
phorolytic enzymes RNase PH or polynucleotide phosphorylase
(PNPase) is close to unity22,23, the reaction being freely reversible
in vitro. The low ∆G for this reaction is because the free energy
released upon disruption of the phosphodiester linkage is largely
recouped by generating the nucleoside diphosphate product.
Little free energy is therefore available for phosphorolytic nucle-
ases to unfold the RNA substrate. In the E. coli degradosome,
PNPase is associated with the endonuclease RNase E and the
ATP-dependent RNA helicase RhlB27,28. Consistent with the pre-
dicted energetics, phosphorolytic degradation of structured
RNA substrates by the degradosome is dependent upon the
activity of RhlB27. In contrast, substantial free energy is released
by RNA hydrolysis and this energy can be utilized by any
hydrolytic exonuclease that is able to couple RNA degradation to
unfolding of the RNA structure. Notably, the Rrp44p-related
3′→5′ exoribonuclease RNase R (also termed vacB) and the
hydrolytic 5′→3′ exoribonucleases Xrn1p and Rat1p exhibit sub-
stantial activity in vitro on structured RNAs such as rRNA and
tRNA in the absence of an associated RNA helicase29–31. In fact,
the energy made available to an exonuclease upon hydrolysis of
the phosphodiester backbone within RNA is comparable to that
generated by an RNA helicase utilizing one molecule of ATP per
nucleotide.
It follows that the ability of the exosome to penetrate regions
of secondary structure and displace bound proteins may be
strongly dependent on which of the nuclease activities has been
activated. Complexes with an activated processive nuclease, such
as Rrp44p, may be able to degrade even highly structured sub-
strates, as would be necessary for the rapid degradation of aber-
rant pre-ribosomes or pre-mRNAs. In contrast, complexes in
which a phosphorolytic enzyme is activated would be predicted
to degrade relatively unstructured regions but would be blocked
by stem loop structures, particularly if these were stabilized by
bound proteins. Such an activity is needed for the processing of
the 3′ extended precursors to mature snRNAs and snoRNAs. In
the case of distributive enzymes, such as Rrp4p, there is no obvi-
ous mechanism for coupling hydrolysis to unfolding RNA struc-
ture and these activities may be limited to trimming short
unstructured 3′ extensions. The fate of exosome substrates
would therefore be expected to depend on which component has
been activated, a structure-sensitive phosphorolytic enzyme for
RNA processing or a structure-insensitive hydrolytic enzyme for
RNA degradation.
A key feature of allosteric models for exosome function is that
the recognition of a particular substrate induces activation of the
appropriate nuclease activity(s). One possible mechanism envis-
ages a modular system in which specific cofactors function as
exosome ‘adaptors’, allowing the complex to dock onto a given
class of substrate13. A ‘one substrate, one adaptor’ rule would in
principle allow highly specific substrate processing/degradation
but would require substantially more cofactors than have been
identified to date. Moreover, Mtr4p, the only known nuclear
cofactor, appears to be required for both processing and degra-
dation of diverse substrates.
Alternatively, the exosome may interact directly with the
RNP structure of its substrates. All exosome substrates charac-
terized so far have undergone prior RNA processing events and
they may well be ‘tagged’ with marker proteins as a result of
such processing. This would be similar to current models for
the degradation of mRNAs with retained introns by RNA sur-
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veillance mechanisms, where proteins that remain associated
with the mRNA after pre-mRNA processing are thought to be
subsequently recognized by the surveillance complex and trig-
ger rapid degradation of the RNA32–34. One possibility is that
Mtr4p (or Ski2p in the case of cytoplasmic mRNAs) directly
recognizes both processing and degradation substrates, either
before or after association with the exosome. Interactions
between Mtr4p or Ski2p and the RNP proteins of the substrate
would then determine which exosome component, or compo-
nents, are activated (Fig. 1b). Such an allosteric activation
could conceivably be driven by the ATPase activities of Mtr4p
or Ski2p.
Perspectives
The RNase complement of the exosome constitutes a remarkably
powerful RNA degradation machine. The genetic analysis of
mutant alleles in yeast has been central in defining the functions
of the complex and identifying its cofactors in RNA processing
pathways. A major limitation to this approach lies in the identifi-
cation of the specific roles of individual components in coopera-
tive complexes. Similar difficulties attend other such analyses, for
example in identifying the endonuclease component of the pre-
mRNA cleavage and polyadenylation machinery. Future work
involving a combination of structural studies on the exosome
and the development of suitable in vitro RNA processing systems
should reveal details of the molecular mechanisms of exosome
mediated RNA degradation.
Acknowledgments
We would like to thank A. van Hoof and R. Parker for sharing data prior to
publication. This work is funded by the Wellcome Trust.
Received 28 July, 2000; accepted 23 August, 2000.
1. Mian, S. Nucleic Acids Res. 25, 3187–3195 (1997).
2. Moser, M.J., Holley, W.R., Chatterjee, A. & Mian, S. Nucleic Acids Res. 25,
5110–5118 (1997).
3. Mitchell, P., Petfalski, E., Schevchenko, A., Mann, M. & Tollervey, D. Cell 91,
457–466 (1997).
4. Allmang, C. et al. Genes Dev. 13, 2148–2158 (1999).
5. Deutscher, M.P. J. Bacteriol. 175, 4577–4583 (1993).
6. Burkard, K.T.D. & Butler, J.S. Mol. Cell. Biol. 20, 604–616 (2000).
7. Allmang, C., et al. EMBO J. 18, 5399–5410 (1999).
8. Allmang, C., Mitchell, P., Petfalski, E. & Tollervey, D. Nucleic Acids Res. 28,
1684–1691 (2000).
9. Kufel, J. et al. Mol. Cell. Biol. 20, 5415–5424 (2000).
10. Bousquet-Antonelli, C., Presutti, C. & Tollervey, D. Cell, in the press (2000).
11. van Hoof, A., Lennertz, P. & Parker, R. Mol. Cell. Biol. 20, 441–452 (2000).
12. de la Cruz, J., Kressler, D., Tollervey, D. & Linder, P. EMBO J. 17, 1128–1140 (1998).
13. Jacobs Anderson, J.S. & Parker, R. EMBO J. 17, 1497–1506 (1998).
14. van Hoof, A. & Parker, R. Cell 99, 347–350 (1999).
15. Baker, R., Harris, K. & Zhang, K. Genetics 149, 73–85 (1998).
16. Shiomi, T. et al. J. Biochem. 123, 883–890 (1998).
17. Baumeister, W., Walz, J., Zühl, F. & Seemüller, E. Cell 92, 367–380 (1998).
18. DeMartino, G.N. & Slaughter, C.A. J. Biol. Chem. 274, 22123–22126 (1999).
19. Rubin, D.M., Glickman, M.H., Larsen, C.N., Dhruvakumar, S. & Finley, D. EMBO J.
17, 4909–4919 (1998).
20. Palombella, V.J., Rando, O.J., Goldberg, A.L. & Maniatis, T. Cell 78, 773–785
(1994).
21. Sears, C., Olesen, J., Rubin, D., Finley, D. & Maniatis, T. J. Biol. Chem. 273,
1409–1419 (1998).
22. Lin, L., DeMartino, G.N. & Greene, W.C. Cell 92, 819–828 (1998).
23. Lin, L. & Ghosh, S. Mol. Cell. Biol. 16, 2248–2254 (1996).
24. Mitchell, P., Petfalski, E. & Tollervey, D. Genes Dev. 10, 502–513 (1996).
25. Ost Kelly, K. & Deutscher, M.P. J. Biol. Chem. 267, 17153–17158 (1992).
26. Grunberg-Manago, M., Ortiz, P.J. & Ochoa, S. Science 122, 907–910 (1955).
27. Py, B., Higgins, C.F., Krisch, H.M. & Carpousis, A.J. Nature 381, 169–172 (1996).
28. Miczak, A., Kaberdin, V. R., Wei, C.-L. & Lin-Chao, S. Proc. Natl. Acad. Sci. USA 93,
3865–3869 (1996).
29. Cheng, Z.-F., Zuo, Y., Li, Z., Rudd, K.E. & Deutscher, M.P. J. Biol. Chem. 272,
14077–14080 (1998).
30. Stevens, A. J. Biol. Chem. 255, 3080–3085 (1979).
31. Kenna, M., Stevens, A., McCammon, M. & Douglas, M.G. Mol. Cell. Biol. 13,
341–350 (1993).
32. Hilleren, P. & Parker, R. RNA 5, 711–719 (1999).
33. González, C.I., Ruiz-Echevarria, M.J., Vasudevan, S., Henry, M.F. & Peltz, S.W. Mol.
Cell 5, 489–499 (2000).
34. Le Hir, H., Moore, M.J. & Maquat, L.E. Genes Dev. 14, 1098–1108 (2000).
© 2000 Nature America Inc. • http://structbio.nature.com
©
 2
00
0 
N
at
u
re
 A
m
er
ic
a 
In
c.
 •
 h
tt
p
:/
/s
tr
u
ct
b
io
.n
at
u
re
.c
o
m
